Inventor · disambiguated record
Biswajit Kalita
Also filed as: KALITA BISWAJIT
4 granted patents·10 pending applications·7 citations·filing 2017–2022
67Inventor score
Top patents by PatentIndex Score
14 records- 0190US11040964B2Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2020·Granted Jun 22, 2021·4 cites·30 claims
- 0284US11547704B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 10, 2023·1 cites·4 claims
- 0374US2023165848A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 0473US11098040B2Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·1 cites·26 claims
- 0572US10851053B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Dec 1, 2020·1 cites·4 claims
- 0660US2023039846A1Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0758US2022002280A1Compounds and methods of useFERRO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0854US2023234943A1Trex1 inhibitors and uses thereofTEMPEST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0952US2019298705A1Chemical CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1048US2022227765A1Pyrido-indole analogues as gpx4 inhibitorsFERRO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1148US2021093619A1Chemical Compounds as ATF-4 Pathway InhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1247US2022227716A1Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitorsFERRO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1342US2021145771A1N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] pentan-1-yl)-2-cyclobutane-1- carboxamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1439US2020140383A12-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →